A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine
- Status
- COMPLETED
- Phase
- PHASE2
Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines
- Status
- COMPLETED
- Phase
- PHASE1
Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04
- Status
- COMPLETED
- Phase
- PHASE3
Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1 Safety and Immunogenicity Study in Healthy Adults of VAX125, a Recombinant HA-flagellin Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Immunogenicity and Safety of GSK Biologicals' FluLaval® TF
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.
- Status
- COMPLETED
- Phase
- PHASE1
Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups
- Status
- COMPLETED
- Phase
- PHASE3
Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity
- Status
- COMPLETED
- Phase
- PHASE3
Pandemic Influenza Plasmid DNA Vaccines (Needle)
- Status
- COMPLETED
- Phase
- PHASE1
Oseltamivir Randomised Controlled Efficacy Trial
- Status
- COMPLETED
- Phase
- PHASE3
A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults
- Status
- COMPLETED
- Phase
- PHASE3